Greenlight Capital Re, Ltd.

NASDAQ:GLRE

Insurance - Reinsurance

Financial Services
$16.37 -0.74%

-$0.12 today

Market cap
$527.77M
Beta
0.33
P/E (TTM)
6.7
EPS (TTM)
$2.41
52W Low $11.57High $19.39

Volume 0.10M

Average 0.21M

GLRE Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Greenlight Capital Re, Ltd.NASDAQ: GLRE

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development remains negative

Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMMar 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Research & Development vs competitors

How GLRE compares with its peers on the latest reported figures

  • GLRE's LTM Mar 2026 research & development of $0 is the highest of the 10 companies compared; the peer median is $0.
  • Research & development amounts to 0.0% of revenue for GLRE, versus a peer median of 0.0%.
GLRE Competitors Peer median
Research & Development for GLRE and competitors
Company Period LTM YoY 3-year CAGR% of revenue
GLREGreenlight Capital Re, Ltd.LTM Mar 2026$0 ——0.0%
EGEverest Re Group, Ltd.LTM Jun 2026$0 ——0.0%
RNRRenaissanceRe Holdings Ltd.LTM Jun 2026$0 ——0.0%
AXSAXIS Capital Holdings LimitedLTM Sep 2026$0 ——0.0%
SPNTSiriusPoint Ltd.LTM Jun 2026$0 ——0.0%
PLGOPelagos Insurance Capital LimitLTM Sep 2026$0 ——0.0%
IGICInternational General Insurance Holdings Ltd.LTM Mar 2026$0 ——0.0%
MHLAMaiden Holdings, Ltd. 6.625 NT 2046LTM Mar 2025$0 ——0.0%
GBLIGlobal Indemnity Group, LLCLTM Mar 2026$0 ——0.0%
JRVRJames River Group Holdings, Ltd.LTM Mar 2026$0 ——0.0%
Peer median (excluding GLRE) $0——0.0%

Competitors are the stored peer set for GLRE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue570.46M477.63M632.35M647.97M696.35M
Cost of Revenue519.94M459.63M528.88M604.04M411.59M
Gross Profit50.52M18M103.46M43.93M284.76M
Gross Margin8.9%3.8%16.4%6.8%40.9%
Research & Development00000
Selling, General & Admin29.37M17.79M23.65M00
Operating Expenses29.2M(6.53M)16.53M365K206.45M
Depreciation & Amortization16K79K000
EBITDA39.26M35.52M94.96M52.75M83.1M
EBITDA Margin6.9%7.4%15.0%8.1%11.9%
Operating Income21.32M24.53M86.93M43.57M78.31M
Operating Margin3.7%5.1%13.7%6.7%11.2%
Interest Income04.47M35.63M32.43M0
Interest Expense17.92M10.92M8.03M9.18M4.79M
Other Income / Expenses00000
Income Before Tax21.32M24.53M86.93M43.57M78.31M
Pre-Tax Margin3.7%5.1%13.7%6.7%11.2%
Income Tax Expense3.75M(816K)100K749K3.48M
Net Income17.58M25.34M86.83M42.82M74.83M
Net Margin3.1%5.3%13.7%6.6%10.7%
EPS (Basic)0.510.752.551.262.21
EPS (Diluted)0.510.642.501.242.17
Weighted Avg Shares34.2M33.91M34.07M34.1M33.82M
Weighted Avg Shares (Diluted)34.35M39.77M34.8M34.65M34.5M

Greenlight Capital Re, Ltd.

NASDAQ:GLRE

Intrinsic Alpha fair value

Locked

Current Price

$16.37

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.